|
|
|
Insider
Information: |
Gagnon Robert E. |
Relationship: |
Director |
City: |
Weston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
359,945 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,481,170 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
359,945 |
|
|
Total
Value |
$3,481,170 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
6
|
Stock
price went down : |
0
|
12
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-310.7%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Vice President, Finance |
2012-02-29 |
3,999 |
|
0 |
Premium* |
|
Clean Harbors Inc |
CLH |
EVP CFO and Treasurer |
2012-09-11 |
7,386 |
2012-09-11 |
0 |
Premium* |
|
Harvard Bioscience Inc |
HBIO |
Chief Financial Officer |
2018-08-29 |
321,169 |
2014-06-16 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2024-03-19 |
27,391 |
2018-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2020-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
290,210 |
503,710 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
217,392 |
474,073 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
177,304 |
242,549 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
148,500 |
584,398 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-07-11 |
4 |
AS |
$5.23 |
$738,999 |
D/D |
(141,300) |
386,829 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-07-11 |
4 |
OE |
$4.12 |
$490,840 |
D/D |
116,272 |
528,129 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-08-07 |
4 |
AS |
$6.08 |
$608,091 |
D/D |
(100,015) |
349,286 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
151,000 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-03-07 |
4 |
S |
$4.62 |
$448,542 |
D/D |
(97,087) |
357,938 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-08-07 |
4 |
OE |
$4.12 |
$420,200 |
D/D |
87,500 |
449,301 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
411,857 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
67,925 |
571,635 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-07-27 |
4 |
AS |
$5.54 |
$346,328 |
D/D |
(62,514) |
361,801 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
213,500 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-07-27 |
4 |
OE |
$4.12 |
$211,700 |
D/D |
50,000 |
424,315 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2018-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,000 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2022-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
607,880 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2021-08-12 |
4 |
D |
$2.87 |
$130,094 |
D/D |
(45,329) |
435,898 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
28,117 |
63,221 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,500 |
35,104 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-05-06 |
4 |
D |
$5.00 |
$130,405 |
D/D |
(26,081) |
331,857 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-01-01 |
4 |
D |
$3.30 |
$66,158 |
D/D |
(20,048) |
455,025 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-11-03 |
4 |
B |
$2.34 |
$46,800 |
D/D |
20,000 |
267,549 |
2.74 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2022-01-03 |
4 |
S |
$2.05 |
$40,205 |
D/D |
(19,612) |
559,289 |
0 |
% |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2022-05-16 |
4 |
S |
$1.03 |
$17,126 |
D/D |
(16,627) |
591,253 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|